Macquarie Reaffirms Outperform Rating for Addus HomeCare (NASDAQ:ADUS)

Addus HomeCare (NASDAQ:ADUS)‘s stock had its “outperform” rating reissued by stock analysts at Macquarie in a note issued to investors on Thursday,Benzinga reports. They currently have a $129.00 price objective on the stock. Macquarie’s target price indicates a potential upside of 34.70% from the stock’s current price.

Several other equities analysts also recently commented on ADUS. Oppenheimer upped their price objective on Addus HomeCare from $145.00 to $150.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Stephens dropped their price target on Addus HomeCare from $153.00 to $142.00 and set an “overweight” rating on the stock in a research report on Wednesday. JMP Securities assumed coverage on Addus HomeCare in a research note on Monday, December 16th. They set an “outperform” rating and a $150.00 price target for the company. StockNews.com cut Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Wednesday. Finally, Citizens Jmp upgraded shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, seven have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, Addus HomeCare presently has an average rating of “Moderate Buy” and a consensus target price of $132.78.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $95.77 on Thursday. The company has a market capitalization of $1.74 billion, a PE ratio of 21.92, a price-to-earnings-growth ratio of 1.41 and a beta of 1.00. Addus HomeCare has a 1 year low of $87.88 and a 1 year high of $136.72. The business has a fifty day moving average price of $122.60 and a two-hundred day moving average price of $126.08.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09). The company had revenue of $297.14 million for the quarter, compared to analysts’ expectations of $291.04 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Sell-side analysts anticipate that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Activity

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of the company’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the transaction, the chief executive officer now directly owns 79,397 shares in the company, valued at $9,905,569.72. This represents a 23.95 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Addus HomeCare

Hedge funds have recently bought and sold shares of the stock. Armis Advisers LLC purchased a new stake in shares of Addus HomeCare during the 4th quarter valued at $295,000. Integrated Advisors Network LLC increased its stake in Addus HomeCare by 8.5% in the fourth quarter. Integrated Advisors Network LLC now owns 4,261 shares of the company’s stock valued at $534,000 after acquiring an additional 333 shares during the last quarter. Public Employees Retirement System of Ohio purchased a new stake in Addus HomeCare during the fourth quarter valued at about $4,985,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Addus HomeCare by 43.7% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 48,727 shares of the company’s stock worth $6,108,000 after purchasing an additional 14,812 shares during the last quarter. Finally, Squarepoint Ops LLC purchased a new position in shares of Addus HomeCare in the 4th quarter worth about $389,000. 95.35% of the stock is currently owned by institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.